FDA recall D-0165-2023

Product

Rifampin Capsules USP, 300 mg, 100 Capsules (10 x 10) per carton, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217, Carton NDC 60687-586-01 (Individual Dose NDC: 60687-586-11)

Reason for recall

Failed Impurities/Degradations Specifications

Distribution

Nationwide in the USA.

Key facts

Status

Terminated

Initiation date

2022-12-20

Report date

2023-01-25

Termination date

2024-09-06

Voluntary/Mandated

Voluntary: Firm initiated

Location

Columbus, OH, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0165-2023